Analyzing ultrafine particles in air for better health assessment
Multispectral Sensor for Chemical Composition Analysis of Ultrafine Aerosols in Air Quality Assessment
['FUNDING_OTHER'] · SPECTREE INC. · NIH-11191101
This study is testing a new way to measure tiny particles in the air that can affect your breathing, using special sensors to see what these particles are made of, so we can better understand how air pollution impacts health, especially for people with respiratory issues.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SPECTREE INC. (nih funded) |
| Locations | 1 site (SEATTLE, UNITED STATES) |
| Trial ID | NIH-11191101 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a new technology to collect and analyze ultrafine particles in the air using a multispectral sensor. By directly capturing samples onto a substrate, the study employs excitation-emission matrix (EEM) spectroscopy to assess the chemical composition of these particles. The goal is to improve personal exposure assessments and understand how different pollutants affect health, particularly in relation to respiratory diseases. The research will validate its findings against various sources of combustion-generated aerosols and environmental pollutants.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in urban areas with high levels of air pollution or those with respiratory conditions exacerbated by air quality.
Not a fit: Patients who do not live in areas affected by air pollution or who do not have respiratory issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better monitoring of air quality and improved health outcomes for individuals exposed to harmful pollutants.
How similar studies have performed: Other research has shown promise in using similar multispectral techniques for environmental monitoring, indicating potential for success in this approach.
Where this research is happening
SEATTLE, UNITED STATES
- SPECTREE INC. — SEATTLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MAMISHEV, ALEXANDER V — SPECTREE INC.
- Study coordinator: MAMISHEV, ALEXANDER V
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.